Surgeon-Guided Serratus Block in Breast Reduction Surgery

Launched by ALPEREN CAN KOKTEN · Mar 25, 2025

Keywords

ClinConnect Summary

This clinical trial is studying a technique called the "surgeon-guided serratus block," which is used during breast reduction surgery to help control pain after the operation. The aim is to see if this technique can reduce the amount of pain patients feel in the first 24 hours after surgery, leading to less need for pain medication and fewer complications. Essentially, if successful, this method could make recovery more comfortable for women undergoing this procedure.

To participate in the trial, women aged 18 to 65 who are scheduled for a specific type of breast reduction surgery and meet certain health criteria can apply. Eligible participants should be generally healthy, without a history of cancer or certain other medical conditions. If you join the study, you'll receive the surgeon-guided serratus block during your surgery, and the research team will monitor your pain levels and medication use afterward. This trial is currently recruiting participants, so if you're interested, it's a good idea to talk to your doctor for more information.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Patient's willingness to be included in the study
• • 18-65 years
• • Woman
• • Operated with inferior pedicled breast reduction technique
• • The distance from the sternal notch to the nipple complex is between 25-40cm
• • ASA I-II
• • Breast Usg result BIRADS 1-2
• • Patients who have not previously received RT to the breast and have no history of malignancy
• Exclusion Criteria:
• • Patient's request/refusal not to be included in the study
• • Previous history of malignancy
• • RT story,
• • ASA 3-4-5-patient group
• • Severe organ failure
• • Alcohol, drug addiction
• • Bupivacaine allergy
• • Diagnosis of psychiatric illness and psychiatric drug use
• • Surgery lasting longer than 3 hours
• • Bleeding diathesis